The interplay of O-H?O hydrogen bonding in the generation of three new supramolecular complexes of Cu, Ni and Co: Syntheses, characterization and structural aspects

Three new coordination complexes, [Cu(L¹)(H₂O)] (1), [Ni(L²)₂]·CH₃CN (2) and [Co(HL³)(L³)] (3) [where H₂L¹, N,N′-bis(3-methoxysalicylidenimino)-1,3-diamino-propane; HL², 2-((E)-(1,3-dihydroxy-2-methylpropan-2-ylimino)methyl)phenol; H₂L³, 2-((E)-(2-hydroxyethylimino)methyl)-4-bromophenol] have been synthesized and systematically characterized by elemental analyses, FT-IR, electronic spectroscopy, cyclic voltammetry and thermogravimetric analyses. Single crystal X-ray diffraction studies confirm that the metal center in complex 1 has distorted square-pyramidal geometry while it is distorted octahedral in the other two complexes. In all the complexes O-H?O hydrogen bondings assemble the molecular units leading to ordered supramolecular architectures. While both complexes 1 and 2 form infinite one-dimensional arrays through the self organisation of hydrogen bonded ring motifs, complex 3 is a unique star-shaped cyclic hexamer generated through intermolecular hydrogen bonding.     

Synthesis of 5-methyl-2,4-dihydro-3H-1,2,4-triazole-3-one’s aryl Schiff base derivatives and investigation of carbonic anhydrase and cholinesterase (AChE,BuChE) inhibitory properties

Carbonic anhydrase enzymes (EC 4.2.1.1, CAs) are metalloenzyme families that catalyze the rapid conversion of H₂O and CO₂ to HCO₃^– and H⁺. CAs are found in different tissues where they participate in various significant biochemical processes such as ion transport, carbon dioxide respiration, ureagenesis, lipogenesis, bone resorption, electrolyte secretion, acid-base balance, and gluconeogenesis. In such processes, many CAs are significant therapeutic targets because of their inhibitory potentials especially in the treatment of some diseases such as edema, glaucoma, obesity, cancer, epilepsy, and osteoporosis. Acetylcholinesterase (AChE) and Butyrylcholinesterase (BuChE) inhibitors are also valuable compounds for different therapeutic applications including Alzheimer’s disease. In this work, we report a fast and effective synthesis of 5-methyl-2,4-dihydro-3H-1,2,4-triazole-3-one’s aryl Schiff base derivatives and also their CA and cholinesterases inhibitory properties. Our findings showed that these Schiff base derivatives, with triazole ring, found as strong CA and cholinesterases inhibitors.     

Syntheses and antitumor activities of N′1,N′3-dialkyl-N′1,N′3-di-(alkylcarbonothioyl) malonohydrazide: The discovery of elesclomol

A series of N′¹,N′³-dialkyl-N′¹,N′³-di(alkylcarbonothioyl) malonohydrazides have been designed and synthesized as anticancer agents by targeting oxidative stress and Hsp70 induction. Structure–activity relationship (SAR) studies lead to the discovery of STA-4783 (elesclomol), a novel small molecule that has been evaluated in a number of clinical trials as an anticancer agent in combination with Taxol.     

Novel bis(β-diketonato)diorganotin(IV) derivatives containing bulky 4-acyl-5-pyrazolonato ligands: Influence of the steric hindrance of the acyl moiety on the solid state structures of tin complexes and their behaviour in solution

New (Q)₂SnR₂ derivatives (HQ in general; in detail: HQ^CHPh₂ = 4-diphenylacetyl-3-methyl-1-phenyl-5-pyrazolone; HQ^Bn = 3-methyl-1-phenyl-4-phenylacetyl-5-pyrazolone; HQ^naph = 3-methyl-4-naphthoyl-1-phenyl-5-pyrazolone; R = CH₃, C₂H₅, C₆H₁₁, n- and t-C₄H₉, C₆H₅,) have been synthesised and characterised by analytical and spectral techniques. Variable temperature NMR studies of (Q^CHPh₂)₂SnR₂ derivatives (R = CH₃ and C₂H₅) in chlorohydrocarbon solvents indicate a fluxional behaviour, with rapid interconversion between six- and five-coordinate species, the latter containing a bidentate acylpyrazolonate and a monodentate one. The X-ray crystal structures of the diorganotin(IV) derivatives (Q^CHPh₂)₂SnMe₂, (Q^CHPh₂)₂SnEt₂, (Q^Bn)₂SnMe₂ and , inclusive of a representative of each Q^x family, show the metal centres in a skewed trans octahedral configuration. The 4-acyl moiety of the β-diketonate donor exerts a steric effect which is correlated to structural behaviour in the solid and solution state. A solid state ¹¹⁹Sn CPMAS NMR study of the (Q^Bn)₂SnR₂ (R = CH₃, C₂H₅, t-C₄H₉ and C₆H₅) complexes shows a marked deshielding effect and upfield movement of the ¹¹⁹Sn isotropic chemical shift (δ_iso) through this series. The ¹¹⁹Sn chemical shift spans (Ω) are the largest reported for directly oxo-coordinated Sn(IV) systems, although the markedly reduced Ω value for the (Q^Bn)₂SnPh₂ complex may be indicative of a cis octahedral coordination, in contrast to the trans octahedral coordination characterising the other complexes of this suite.     

The solid state chemistry of uranium. Part I: The thermal decomposition of U(NO3)4·2tdpo and U(NO3)4·2tppo

The thermal decomposition of U(NO₃)₄·2tdpo (tdpo=tris-(dimethylamino)phosphine oxide) and U(NO₃)₄·2tppo (tppo=triphenyl phosphine oxide have been examined using thermogravimetry and differential scanning calorimetry. Decomposition of the crystals approximates to the general reaction U(NO₃)₄·2L(s) → UO₂(NO₃)₂·2L(s) + gases The general thermal behaviour of the two compounds were found to be different.     

3-Aryl/Heteroaryl-5-amino-1-(3′,4′,5′-trimethoxybenzoyl)-1,2,4-triazoles as antimicrotubule agents. Design,synthesis, antiproliferative activity and inhibition of tubulin polymerization

Many natural and synthetic substances are known to interfere with the dynamic assembly of tubulin, preventing the formation of microtubules. In our search for potent and selective antitumor agents, a novel series of 1-(3′,4′,5′-trimethoxybenzoyl)-5-amino-1,2,4-triazoles were synthesized. The compounds had different heterocycles, including thiophene, furan or the three isomeric pyridines, and they possessed a phenyl ring bearing electron-releasing or electron-withdrawing substituents at the 3-position of the 5-amino-1,2,4-triazole system. Most of the twenty-two tested compounds showed moderate to potent antiproliferative activities against a panel of solid tumor and leukemic cell lines, with four (5j, 5k, 5o and 5p) showing strong antiproliferative activity (IC₅₀ < 1 μM) against selected cancer cells. Among them, several molecules preferentially inhibited the proliferation of leukemic cell lines, showing IC₅₀ values 2-100-fold lower for Jurkat and RS4;11 cells than those for the three lines derived from solid tumors (HeLa, HT-29 and MCF-7 cells). Compound 5k strongly inhibited tubulin assembly, with an IC₅₀ value of 0.66 μM, half that obtained in simultaneous experiments with CA-4 (IC₅₀ = 1.3 μM).     

Uric acid salts of magnesium: crystal and molecular structures and thermal analysis of two phases of Mg(C5H3N4O3)2 · 8H2O

Two structurally different phases of a uric acid salt of magnesium, Mg(hydrogenurate)₂ · 8H₂O, have been prepared by crystallization from solution at pH = 7.5–8.0 and were investigated by x-ray crystallography, thermal analysis, and ir spectroscopy. Both phases are monoclinic, space group P2₁/c with a = 9.573(2), b = 14.627(3), c = 7.170(1) Å, β = 101.91(1)° (phase I) and a = 10.397(2), b = 14.306(3), c = 6.732(1) Å, β = 104.64(2)° (phase II). The crystal structures of both phases (R = 0.053 and 0.051, respectively) contain isolated octahedral [Mg(H₂O)₆]²⁺ cations, hydrogenurate monoanions, and two molecules of water of crystallization per formula unit. The structural formula representing these facts is [Mg(H₂O)₆] (hydrogenura-te)₂·2H₂O. The tautomeric form of the hydrogenurate molecule corresponds to the tri-keto form of uric acid deprotonated at N(3). Differences in bond length between uric acid and the hydrogenurate molecule may be described in terms of three additional resonance structures distributing the formal negative charge at N(3) within the pyrimidine (but not the imidazole) ring. Deprotonation at N(3) significantly decreases the internal C-N-C angle at N(3). Alternating pairs of medium-strong intermolecular N-HO hydrogen bonds lead to infinite chains of hydrogenurate molecules extending along the b axis of the unit cells in both phases. The main difference between the two phases lies in their stacking pattern of the hydrogenurate molecules. Infrared data confirm the hydrogen bonding characteristics resulting from the crystal structure analysis. Thermogravimetric measurements and differential scanning calorimetry data show that the dehydration of both phases occurs in two distinct steps with Mg(hydrogenurate)₂.6H₂O as an intermediate phase. The first dehydration step (−2H₂O) is a topotactic reaction with three-dimensional preservation of the main structure elements of the octahydrate in the structure of the hexahydrate.     

Synthesis and crystal structure of a new macrocyclic dimethyltin(IV) complex with 5-phenyl-1,3,4-oxadiazole-2-thiol linked by intermolecular CS?O non-bonded weak interactions

A new macrocycle dimethyltin(IV) complex 1 has been synthesized by the reaction of 5-phenyl-1,3,4-oxadiazole-2-thiol with dimethyltin dichloride in the presence of sodium ethoxide. The complex 1 has been characterized by elemental, IR, ¹H, ¹³C, ¹¹⁹Sn NMR spectra and X-ray crystallography diffraction analyses. X-ray data reveal that a 24-membered macrocycle associated by intermolecular CS?O non-bonded weak interactions. The geometry about each tin atom involved is distorted trigonal bipyramidal.     

Accommodating a nonconservative internal mutation by water-mediated hydrogen bonding between β-sheet strands: a comparison of human and rat type B (mitochondrial) cytochrome b5

Mammalian type B (mitochondrial) b(5) cytochromes exhibit greater amino acid sequence diversity than their type A (microsomal) counterparts, as exemplified by the type B proteins from human (hCYB5B) and rat (rCYB5B). The comparison of X-ray crystal structures of hCYB5B and rCYB5B reported herein reveals a striking difference in packing involving the five-strand β-sheet, which can be attributed to fully buried residue 21 in strand β4. The greater bulk of Leu21 in hCYB5B in comparison to that of Thr21 in rCYB5B results in a substantial displacement of the first two residues in β5, and consequent loss of two of the three hydrogen bonds between β5 and β4. Hydrogen bonding between the residues is instead mediated by two well-ordered, fully buried water molecules. In a 10 ns molecular dynamics simulation, one of the buried water molecules in the hCYB5B structure exchanged readily with solvent via intermediates having three water molecules sandwiched between β4 and β5. When the buried water molecules were removed prior to a second 10 ns simulation, β4 and β5 formed persistent hydrogen bonds identical to those in rCYB5B, but the Leu21 side chain was forced to adopt a rarely observed conformation. Despite the apparently greater ease of access of water to the interior of hCYB5B than of rCYB5B suggested by these observations, the two proteins exhibit virtually identical stability, dynamic, and redox properties. The results provide new insight into the factors stabilizing the cytochrome b(5) fold.     

Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P₁ agonists

S1P(1) receptor driven lymphopenia has proven utility in the treatment of an array of autoimmune disease states. As a part of our efforts to develop potent and selective S1P(1) receptor agonists, we have identified a novel chemical series of 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acid S1P(1) receptor agonists.     

Synthesis of novel 2-amino-4-(5′-substituted 2′-phenyl-1H-indol-3′-yl)-6-aryl-4H-pyran-3-carbonitrile derivatives as antimicrobial and antioxidant agents

As a part of systematic investigation of synthesis and biological activities of indole analogues linked to various heterocyclic systems, we have synthesized new compounds viz., 2-amino-4-(5′-substituted 2′-phenyl-1H-indol-3′-yl)-6-aryl-4H-pyran-3-carbonitriles (2a–i), 4,5-diamino-6-(5′-substituted 2′-phenyl-1H-indol-3′-yl)-8-aryl-2-oxo-2,6-dihydrodipyrano [2,3-b:3,2-e]pyridine-3-carbonitriles (3a–i), 4-amino-5-(5′-substituted 2′-phenyl-1H-indol-3-yl)-7-aryl-1H-pyrano[2,3-d]pyrimidin-2(5H)-ones (4a–i), 4-amino-5-(5′-substituted 2′-phenyl-1H-indol-3′-yl)-7-aryl-1H-pyrano[2,3-d]pyrimidin-2(5H)-thiones (5a–i), 4-(5′-subtituted 2′-phenyl-1H-indol-3′-yl)-6-aryl-1,4-dihydropyrano[2,3-c]pyrazol-3-amines (6a–i) and 5-(5′-substituted 2′-phenyl-1H-indol-3′-yl)-7-aryl-3H-pyrano[2,3-d]pyrimidin-4(5H)-ones (7a–i). Antibacterial activity results revealed that, compound 6a showed promising activity versus Escherichia coli, Staphylococcus aureus and Klebsiella pneumoniae. Compound 6d exhibited good activity against S. aureus, K. pneumoniae and Pseudomonas aeruginosa. Antifungal activity results indicated that, compound 4d exhibited maximum zone of inhibition against Aspergillus oryzae and Aspergillus flavus. In case of antioxidant activity, compound 4a showed promising radical scavenging activity, ferric ions (Fe³⁺) reducing antioxidant power (FRAP) and metal chelating activity.     

Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A1 and A2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells

In this work, an enlarged series of 1,2,4-triazolo[4,3-a]pyrazin-3-ones was designed to target the human (h) A_2A adenosine receptor (AR) or both hA₁ and hA_2A ARs. The novel 8-amino-1,2,4-triazolopyrazin-3-one derivatives 1–25 featured a phenyl or a benzyl pendant at position 2 while different aryl/heteroaryl substituents were placed at position 6. Two compounds (8 and 10) endowed with high affinity (K_i = 7.2 and 10.6 nM) and a complete selectivity for the hA_2A AR were identified. Moreover, several derivatives possessed nanomolar affinity for both hA₁ and hA_2A ARs (both K_i < 20 nM) and different degrees of selectivity versus the hA₃ AR. Two selected compounds (10 and 25) demonstrated ability in preventing β-amyloid peptide (25–35)-induced neurotoxicity in SH-SY5Y cells. Results of docking studies at the hA_2A and hA₁ AR crystal structures helped us to rationalize the observed affinity data and to highlight that the steric hindrance of the substituents at the 2- and 6-position of the bicyclic core affects the binding mode in the receptor cavity.     

The N1-(3′-Deoxythymidin-3′-yl)-N2-cyano-N3-(5′-deoxythymidin-5′-yl) Guanidine Dimeric Building Block in Automated DNA Synthesis and Mass Spectrometric Analysis of Its Integrity

Abstract

Nucleoside dimers with an N-cyanoguanidine linkage were synthesized and incorporated in oligonucleotides on an automated DNA synthesizer. The integrity of the dimer was investigated using mass spectrometry.     

Synthesis, crystal structures, and spectroscopic characterization of the neutral monomeric tetrahedral [M(Diap)2(OAc)2] · H2O complexes (M = Zn,Cd; Diap = 1,3-diazepane-2-thione; OAc = acetate) with N-H?O and O-H?O intra- and intermolecular hydrogen bonding interactions

The title complexes, [M(Diap)₂(OAc)₂] · H₂O (M = Zn,Cd; Diap = 1,3-diazepane-2-thione; OAc = acetate) with an MO₂S₂ configuration, have been characterized by X-ray crystallography as well as FT-IR, ¹H and ¹³C NMR spectroscopy. In these complexes, the metal atoms lie in a pseudo-tetrahedral environment and are coordinated by the thione sulfur atoms of two neutral 1,3-diazepane-2-thione ligands and one oxygen atom from each of two monodentate acetate anions. In both complexes, there are two intramolecular N-H?O hydrogen bonds, each being between one NH group of a Diap ligand and the uncoordinated O atom of an OAc ligand. The water molecule is also involved in hydrogen bonds, as an acceptor and as a donor twice, linking together three symmetry-related complexes. The Cd complex undergoes a structural phase transition from a monoclinic form at 150 K with Z′ = 2 to a smaller monoclinic cell at room temperature with Z′ = 1 without loss of crystallinity. The Zn complex does not exhibit an equivalent phase transition, and at 150 K is isostructural with the room-temperature form of the Cd complex. All three crystallographically independent molecules found for the Cd complex (two at low temperature and one at room temperature) have essentially the same structure except for small changes in the conformations of the ligands. Tetrahedral coordination with monodentate carboxylate ligands is common for Zn complexes of this kind, but is unusual for Cd complexes, and is the result of the bulky Diap ligands.     

4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5(3)-(6-methylpyridin-2-yl)imidazole and -pyrazole derivatives as potent and selective inhibitors of transforming growth factor-β type I receptor kinase

A series of 4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5(3)-(6-methylpyridin-2-yl)imidazoles and -pyrazoles 14a–c, 15a–c, 16a, 16b, 19a–d, 21a, and 21b has been synthesized and evaluated for their ALK5 inhibitory activity in an enzyme assay and in a cell-based luciferase reporter assay. Among them, the pyrazole derivative 21b inhibited ALK5 phosphorylation with an IC₅₀ value of 0.018 μM and showed 95% inhibition at 0.03 μM in a luciferase reporter assay using HaCaT cells permanently transfected with p3TP-luc reporter construct. The 21b showed a high selectivity index of 284 against p38α MAP kinase. The binding pose of 21b generated by docking analysis reveals that it fits well into the ATP binding cavity of ALK5 by forming several hydrogen bond interactions.     

f-Element/crown ether complexes. 26. Crystallization of two hydrated forms of hydrogen bonded complexes of NdCl3·nH2O and 15-crown-5. Crystal structures of [Nd(OH2)9]Cl3·15-crown-5·H2O and [NdCl2(OH2)6]Cl·15-crown-5

When slowly evaporated, the reaction of NdCl₃· nH₂O with 15-crown-5 in a 3:1 mixture of acetonitrile:methanol produces two crystalline hydrates. The decahydrate, [Nd(OH₂)₉]Cl₃·15-crown-5·H₂O, is orthorhombic, P2₁2₁2₁, with (at −150 °C) a = 10.571(4), b = 15.220(7), c = 15.686(7) Å, and D_calc = 1.71 g cm⁻³ for Z = 4. These crystals are stable to the moisture in air. Each Nd is nine-coordinate with tricapped trigonal prismatic geometry. The nine coordinated water molecules are hydrogen bonded to two symmetry related crown ethers, all three chloride ions, and the tenth water molecule. The crown has a total of six hydrogen bonds, four on one side (two to a single oxygen atom) and two on the other. This ether exhibits conformational disorder. The hexahydrate, [NdCl₂(OH₂)₆]Cl·15-crown-5 is deliquescent, dissolving in air and recrystallizing as [NdCl₂(OH₂)₆]Cl. Crystals of this complex are monoclinic, P2₁/n, with (at 20 °C) a = 9.821(3), b = 16.978(9), c = 12.849(8) Å, β = 94.06(5)°, and D_calc = 1.80 g cm⁻³ for Z = 4. The Nd atom exists in a distorted dodecahedral geometry with one chlorine in an A site and one in a B site. The coordinated chlorine atoms accept hydrogen bonds producing polymeric zigzag hydrogen bonded chains along c. The third noncoordinated chloride ion accepts four hydrogen bonds, three from one formula unit and one from a second formula unit related by a unit translation along a. The crown ethers accept five hydrogen bonds, two on one side, and three on the other, thus separating the zigzag chains along b.     

The structures and inhibitory effects of Buame [N-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-butylamine] and Diebud [N,N'-bis-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-1,4-butanediamine] on platelet aggregation

Compounds with estrogenic effects that also inhibit platelet aggregation might be useful in reducing thrombotic events associated with estrogenic therapy. In this study, two aminoestrogens, Buame [N-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-butylamine] and Diebud [N,N'-bis-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-1,4-butanediamine], were synthesized and characterized using common analytical methods and spectrophotometric analyses. The location and orientation of these molecules on the estrogenic receptor α (ERα) were also evaluated. Platelet inhibitory effects were elucidated ADP-induced platelet aggregation and ADP- and collagen-induced ATP release. Molecular docking demonstrated that Buame can reach and bind to the ERα in the ligand binding domain (LBD) similar to 17β-estradiol (co-crystallized ligand). On the other hand, Diebud binds only to the surface of ERα due to its high molecular volume compared to 17β-estradiol and Buame.